https://www.auntminnie.com/clinical-news/mri/article/15829958/petition-asks-fda-to-implement-new-rule-for-mri-safetyAuntMinnieen2026-07-14T20:02:24.000ZPetition asks FDA to implement new OEM rule for MRI safetyhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/toby-gilk-cropped.sSPmWTKHyW.png?auto=format%252Ccompress&q=70MR Safety Officer Tobias Gilkhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/mri-scanner2-social.PfQrh4MuTx.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/womens-imaging/article/15830012/incorrect-ai-suggestions-influence-reader-performance-on-mammographyAuntMinnieen2026-07-14T19:34:28.000ZIncorrect AI suggestions influence reader performance on mammographyhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%252Ccompress&q=70A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during <strong>(A)</strong> unaided (round 1) and <strong>(B)</strong> artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.https://www.auntminnie.com/clinical-news/molecular-imaging/article/15830001/brain-pet-scans-reveal-neuron-loss-in-long-covidAuntMinnieen2026-07-14T18:51:54.000ZBrain PET scans reveal neuron loss in long COVIDhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/long-covid-dopamine.vPPvWQrzs4.jpg?auto=format%252Ccompress&q=70Representative participant from each group shown. C-11 DTBZ non-displaceable binding potential (BPND) in voxels quantitated with simplified reference tissue model 2. Color scale indicates C-11 DTBZ BPND from 0 (black) to 3.5 (red), with reduced C-11 DTBZ BPND observed in the long COVID case compared to both healthy controls.https://www.auntminnie.com/clinical-news/digital-x-ray/article/15829928/first-human-xrays-in-space-deemed-diagnosticAuntMinnieen2026-07-14T15:13:17.000ZFirst human x-rays in space deemed diagnostichttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/space-x-rays.5MSIvQ3Ot5.jpg?auto=format%252Ccompress&q=70Representative preflight, in-flight, and postflight chest radiographs. Radiographs of the chest were acquired (A) preflight by a crewmember, (B, C) in-flight on day 3 after launch (L+3) by a crewmember, and (D) postflight by a non-crew operator using the same imaging protocol.https://www.auntminnie.com/clinical-news/womens-imaging/article/15829915/breast-cancer-screening-higher-among-civically-engaged-womenAuntMinnieen2026-07-14T15:08:18.000ZBreast cancer screening higher among civically engaged womenhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/mammogram-calendar-400.9uXdfq39SH.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/15829820/clinical-tool-can-reduce-the-use-of-cpta-in-cancer-patientsAuntMinnieen2026-07-13T16:43:08.000ZClinical tool can reduce the use of CPTA in cancer patientshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/pe.7pTmhE3JS9.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/radiation-oncology-therapy/article/15829803/astro-highlights-study-on-disappearing-radiation-oncology-centersAuntMinnieen2026-07-10T20:19:27.000ZASTRO highlights study on disappearing radiation oncology centershttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/astro-ro-map.juUWjYC9OA.jpg?auto=format%252Ccompress&q=70County-level net change in radiation oncology practice sites from first appearance through 2025.https://www.auntminnie.com/editors-note/article/15829811/week-in-review-new-treatment-response-criteria-lumbar-spinal-stenosis-grading-ultrasound-minniecast-episode-12AuntMinnieen2026-07-10T20:14:52.000ZWeek in Review: New treatment response criteria | Lumbar spinal stenosis grading | Ultrasound MinnieCast, Episode 12https://www.auntminnie.com/clinical-news/ct/article/15829808/ccta-finds-coronary-disease-in-half-of-men-with-erectile-dysfunctionAuntMinnieen2026-07-10T20:11:39.000ZCCTA finds coronary disease in men with erectile dysfunctionhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/ctca.Q6Zi2mqpOH.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/15829799/marijuana-use-linked-to-greater-coronary-plaque-burdenAuntMinnieen2026-07-10T17:54:43.000ZMarijuana use linked to greater coronary plaque burdenhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/marijuana.CHBwq3RnuW.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/womens-imaging/article/15829784/cem-on-par-with-mri-for-breast-cancer-diagnosis-local-stagingAuntMinnieen2026-07-10T16:54:35.000ZCEM on par with MRI for breast cancer diagnosis, local staginghttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-10-jmiro-savaridas-cem-mri.eGEluL01Ze.jpg?auto=format%252Ccompress&q=70MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).https://www.auntminnie.com/clinical-news/molecular-imaging/article/15829699/new-pet-tracer-show-promise-in-neuroblastomaAuntMinnieen2026-07-09T20:47:58.000ZNew PET tracer show promise in neuroblastomahttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/cancer-target.MGK6YXMcTD.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/15829530/arguided-localization-may-sub-for-ct-for-earlystage-lung-cancerAuntMinnieen2026-07-08T16:02:39.000ZAR-guided localization may sub for CT for early-stage lung cancerhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/lungs-3d-research-400.dauj12UaZZ.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/15829484/study-backs-ldct-lung-cancer-screening-in-singaporeAuntMinnieen2026-07-08T15:58:06.000ZStudy backs LDCT lung cancer screening in Singaporehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/lungs.TxolHCRlhW.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/article/15829477/new-criteria-evaluates-treatment-response-in-bone-metastasesAuntMinnieen2026-07-07T20:27:27.000ZNew criteria evaluates treatment response in bone metastaseshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/recibm-response-criteria.Vy3oU99vuA.jpg?auto=format%252Ccompress&q=70Response Evaluation Criteria in Bone Metastases (RECIBM) and metabolic criteria were used to detect a complete response missed at anatomic assessment. A 76-year-old male patient presented with 1 month of hemoptysis and was diagnosed with small cell lung cancer and bone metastases. Baseline (July 2022) F-18 FDG-PET/CT images (A, maximum intensity projection image; B–E, axial images) demonstrate FDG-avid lesions in the left lamina of the first lumbar vertebra (L1) (straight yellow arrows; maximum standardized uptake value, 2.74; peak standardized uptake value normalized to lean body mass, 1.59) and left ilium (curved yellow arrows; maximum standardized uptake value, 3.68; peak standardized uptake value normalized to lean body mass, 2.28). After seven chemotherapy cycles (December 2022), follow-up PET/CT images (F, maximum intensity projection image; G–J, axial images) show complete metabolic resolution of bony lesions (L1: maximum standardized uptake value, 1.32, and peak standardized uptake value normalized to lean body mass, 0.85; left ilium: maximum standardized uptake value, 1.48, and peak standardized uptake value normalized to lean body mass, 0.82), without apparent osteolytic or osteoblastic changes at CT. Assessment was stable disease (SD) according to the University of Texas MD Anderson Cancer Center (MDA) criteria but complete response (CR) or complete metabolic response (CMR) according to RECIBM, PET Response Criteria in Solid Tumors (PERCIST), and European Organization for Research and Treatment of Cancer (EORTC) criteria. The patient was alive as of September 30, 2025.